A signal processing-based Bioinformatics approach to assessing drug resistance: Human Immunodeficiency Virus as a case study

2010 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC'10

Volumn , Issue , 2010, Pages 1836-1839

  Nwankwo, Norbert ^a   Seker, Huseyin ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS METHODS; BIOMEDICAL DATA; DIGITAL SIGNALS; DRUG RESISTANCE; EXPERIMENTAL ANALYSIS; EXPERIMENTAL PROCEDURE; HIV/AIDS; HUMAN IMMUNODEFICIENCY VIRUS; PEAK AMPLITUDE; PROTEIN RESIDUES; RESISTANT STRAINS; SPECTRUM METHOD; THERAPEUTIC AGENTS; TRANSMEMBRANE GLYCOPROTEINS;

AMINO ACIDS; BIOINFORMATICS; BIOLOGY; DISEASES; EXPERIMENTS; LABORATORIES; PROTEINS; SIGNAL PROCESSING;

VIRUSES;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DARUSENTAN; ENFUVIRTIDE; GLYCOPROTEIN GP 41; LAMIVUDINE; PEPTIDE FRAGMENT; PHENYLPROPIONIC ACID DERIVATIVE; PYRIMIDINE DERIVATIVE;

AMINO ACID SEQUENCE; ARTICLE; BIOLOGY; DRUG RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MUTATION; SIGNAL PROCESSING;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; COMPUTATIONAL BIOLOGY; DRUG RESISTANCE; HIV; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HUMANS; LAMIVUDINE; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDE FRAGMENTS; PHENYLPROPIONATES; PYRIMIDINES; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 78650817470     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/IEMBS.2010.5626439     Document Type: Conference Paper

References (20)

1. Chen F. and Lo F., "Molecular Mechanism of Fluoroquine Resistance", J. Microbiol Immunol Infect, vol.36, pp 1-9, 2003.
2. Fidock D. A. et al, "Mutations in the P. falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine Resistance", Molecular Cell, vol. 6, pp 861871, 2000.
3. Stanford University HIV Drug Resistance Database:- http://hivdb.stanford. edu/index.html. Last accessed 8th April 2010.
4. Menendez-Arias L. et al, "Molecular basis of Human Immunodeficiency Virus drug resistance: an update", Antiviral Research, vol. 8, pp. 210-231, 2010.
5. W.- Rimsky L.T. et al, "Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides", J. Virol, vol. 72, pp. 986-993, 1998.
6. Lazar G. A et al, "Designing proteins for therapeutic applications, Current Opinion in Structural Biology", vol. 13, pp 513-518, 2003.
7. Huang H., Chopra R., Verdine G.L., Harrison S.C., "Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance", Science vol. 282, 1998, pp 1669-75.
8. Sarafianos S.G., Das K., et al, "Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with -branched amino acids", Proc. Natl. Acad. Sci. USA, vol.96, 1999, pp.10027-32.
9. Shafer1 R.W et al, "HIV-1 Drug Resistance Mutations: an Updated Framework for the Second Decade of HAART", AIDS Rev., vol. 10, pp 67-84, 2008.
10. Johnson V.A. et al, "Update of the drug resistance mutations in HIV- 1", Top. HIV Med. vol. 16, 2008, pp 138-145.
11. Veljkovic V, Cosic I, Dimitrijevic B, Lalovic D., "Is it possible to analyze DNA and protein sequence by the method of digital signal processing?", IEEE Trans Biomed Eng., vol. 32(5), 1985, pp 337-41
12. Stanford University HIVDB Release Notes for HIVdb, HIVseq, HIValg:- http://hivdb.stanford.edu/pages/asi/releaseNotes/.
13. GenomeNet Database Resources: http://www.genome.jp/aaindex/.
14. Stanford Uni. HIVDB HIV drug resist. summaries (Fusion Inhibitor Resistance Notes) http://hivdb.stanford.edu/cgibin/FIResiNote.cgi.
15. Stanford University HIVDB HIV Rrug Resistance Summaries (PI Resistance Notes) http://hivdb.stanford.edu/cgi-bin/PIResiNote.cgi.
16. Stanford Univ. HIVDB for HIV Drug Resistance Summaries (NRTI Resistance Notes) http://hivdb.stanford.edu/cgibin/NRTIResiNote.cgi.
17. Veljkovic V. and Veljkovic N., "Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control," BMC Structural Biology, 9(21), 2009, pp 1-10.
18. S. Catherine et.al., "Novel approaches to inhibiting HIV-1 replication", Antiviral Research, 85, 2010, pp 119-41.
19. Hoj L., Kjaer J. et al, "Insilico identification of physiochemical properties at mutating position positions relevant to reducing susceptibility to Amprenavir", XVII International HIV Drug Resistance Workshop, Poster No.113, 2008.
20. Veljkovic V, Veljkovic N. et al, NEW: Prediction of efficacy of A/H1N1, Available : http://www.bioprotection.org/